foxo4-dri senolytic 2023 2024 study regulates endothelial cell senescence via the P53 signaling pathway FOXO4-DRI: The Senolytic Peptide That

This peptide is intended for laboratory research and scientific study only

Sign of toxicity include diarrhoea and generalised body oedema Dosage: The most common dosage is 1000mcg which is 1 ml per treatment every 4-6 weeks This can be given via IM injection in the arm or the bum

Preclinical studies suggest it modulates nitric oxide pathways and growth-factor expression to promote angiogenesis and collagen deposition in damaged tissues [1] [3]

Muscle growth & anabolism Studied preclinically as a long-acting IGF-1 analog for anabolic signaling and skeletal muscle protein synthesis

It is the buyers responsibility to ensure all purchases comply with applicable laws and regulations